CAZypedia needs your help! We have many unassigned GH, PL, CE, AA, GT, and CBM pages in need of Authors and Responsible Curators.
Scientists at all career stages, including students, are welcome to contribute to CAZypedia. Read more here, and in the 10th anniversary article in Glycobiology.
New to the CAZy classification? Read this first.
*
Consider attending the 15th Carbohydrate Bioengineering Meeting in Ghent, 5-8 May 2024.

Difference between revisions of "User:Alex Anderson"

From CAZypedia
Jump to navigation Jump to search
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
[[Image:Aa.jpg|200px|right]]
 
[[Image:Aa.jpg|200px|right]]
  
Alex Anderson recieved his BScH from Wilfrid Laurier University in 2017, and began his foray into microbiology as a diagnostic laboratory technician at the Public Health Ontario Laboratories where he became fascinated with microbial cell surface structure and function. Alex is currently a Masters candidate in the lab of Dr. Joel Weadge at WLU where he studies the structure and function of CAZymes responsible for the biosynthesis, modification and export of cellulosic materials involved in biofilm formation in Gram-negative pathogens.
+
Dr. Anderson recieved his BSc (2017) and MSc (2019) from Wilfrid Laurier University (Canada) in the lab of Dr. [[User:Joel Weadge|Joel Weadge]], alongside [[User:Michael Suits|Michael Suits]], at WLU where he studied the structure and function of the cellulose phosphoethanolamine transferase BcsG in ''E. coli''. Dr. Anderson received his Ph.D. from the University of Guelph in 2024 under the supervision of Dr. [[User:Anthony Clarke|Anthony Clarke]] where he worked on the mechanism of peptidoglycan ''O''-acetyltransferases. Dr. Anderson is presently a postdoctoral fellow at McMaster University in the lab of Dr. John Whitney where he studies Type VI-secreted polymorphic toxins that target carbohydrate structures.
 +
 +
 
 +
Dr. Anderson and colleagues have demonstrated the structures of:
 +
 
 +
CAZy-unclassified ''Escherichia coli'' phosphoethanolamine transferase BcsG (6PCZ/6PD0) <cite>Anderson2020</cite>
 +
 
 +
[[GH5]] ''Clostridioides difficile'' endo-β-glucanase CcsZ (6UJE/6UJF) <cite>Scott2020</cite>
 +
 
 +
CAZy-unclassified ''Campylobacter jejuni'' peptidoglycan O-acetyltransferase PatB (8TLB)
 +
 +
 
 +
----
 +
 
 +
<biblio>
 +
#Anderson2020 pmid=32152228
 +
#Scott2020 pmid=33264329
 +
</biblio>
 +
 
  
 
<!-- Do not remove this Category tag -->
 
<!-- Do not remove this Category tag -->
 
[[Category:Contributors|Anderson,Alex]]
 
[[Category:Contributors|Anderson,Alex]]

Latest revision as of 13:18, 23 April 2024

Aa.jpg

Dr. Anderson recieved his BSc (2017) and MSc (2019) from Wilfrid Laurier University (Canada) in the lab of Dr. Joel Weadge, alongside Michael Suits, at WLU where he studied the structure and function of the cellulose phosphoethanolamine transferase BcsG in E. coli. Dr. Anderson received his Ph.D. from the University of Guelph in 2024 under the supervision of Dr. Anthony Clarke where he worked on the mechanism of peptidoglycan O-acetyltransferases. Dr. Anderson is presently a postdoctoral fellow at McMaster University in the lab of Dr. John Whitney where he studies Type VI-secreted polymorphic toxins that target carbohydrate structures.


Dr. Anderson and colleagues have demonstrated the structures of:

CAZy-unclassified Escherichia coli phosphoethanolamine transferase BcsG (6PCZ/6PD0) [1]

GH5 Clostridioides difficile endo-β-glucanase CcsZ (6UJE/6UJF) [2]

CAZy-unclassified Campylobacter jejuni peptidoglycan O-acetyltransferase PatB (8TLB)



  1. Anderson AC, Burnett AJN, Hiscock L, Maly KE, and Weadge JT. (2020). The Escherichia coli cellulose synthase subunit G (BcsG) is a Zn(2+)-dependent phosphoethanolamine transferase. J Biol Chem. 2020;295(18):6225-6235. DOI:10.1074/jbc.RA119.011668 | PubMed ID:32152228 [Anderson2020]
  2. Scott W, Lowrance B, Anderson AC, and Weadge JT. (2020). Identification of the Clostridial cellulose synthase and characterization of the cognate glycosyl hydrolase, CcsZ. PLoS One. 2020;15(12):e0242686. DOI:10.1371/journal.pone.0242686 | PubMed ID:33264329 [Scott2020]

All Medline abstracts: PubMed